DeepMind Reveals First Commercial Product

DeepMind, a British Artificial Intelligence company, has created a working prototype of a device that can diagnose complicated eye diseases in live time, in a major advancement towards the Alphabet-owned company’s first medical device.

In a real-time demonstration of its AI system, where a patient agreed to be examined publicly, DeepMind performed a retinal scan and live diagnosis of her eye. The scan was analysed by a series of algorithms in Google Cloud, which provided an urgency score and a detailed diagnosis, all in about 30 seconds. This system is able to detect a range of eye diseases — including glaucoma, diabetic retinopathy and age-related macular degeneration — with the same level of accuracy as the world’s leading specialists.

The device can diagnose a range of eye diseases, in real time, as accurately as the best specialists

The device can diagnose a range of eye diseases, in real time, as accurately as the best specialists

It was developed in conjunction with London’s Moorfields Eye Hospital over the previous three years, with details about the research published in Nature Medicine, the scientific journal, last August.

DeepMind claims its product will not only offer diagnoses, but will also be able to explain exactly how it arrived at its conclusion and how certain it is of the result, which is crucial for healthcare professionals.

For an ophthalmologist, this is jaw-dropping. What you can see is [the AI] has segmented every single point, about 65m data points in this scan [creating] super high-resolution images. We have to bring the same levels of rigour [to] how we validate the algorithms that we would with any medical device, but my personal prejudice is that ophthalmology will be the first speciality of medicine that is fundamentally transformed by AI.
— Pearse Keane, a consultant ophthalmologist at Moorfields